| David George Anthony, | |
|
1617 W 26th St Ste B, Joplin, MO 64804-0394 | |
| (417) 392-0816 | |
| Not Available |
| Full Name | David George Anthony |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 14 Years |
| Location | 1617 W 26th St Ste B, Joplin, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043510019 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AT006190 (Pennsylvania) | Secondary |
| 231H00000X | Audiologist | 2011039545 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Freeman Health System - Freeman West | Joplin, MO | Hospital |
| Provider Name | Freeman-oak Hill Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679517023 PECOS PAC ID: 8325942253 Enrollment ID: O20040218000570 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
The number of women dying due to complications during pregnancy and childbirth has decreased by 34% from an estimated 546 000 in 1990 to 358 000 in 2008, according to a new report, Trends in maternal mortality, released by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Bank.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
› Verified 6 days ago
| Provider Name | Four States Hearing Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538870357 PECOS PAC ID: 6406229293 Enrollment ID: O20230225000123 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
The number of women dying due to complications during pregnancy and childbirth has decreased by 34% from an estimated 546 000 in 1990 to 358 000 in 2008, according to a new report, Trends in maternal mortality, released by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Bank.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David George Anthony, 1617 W 26th St Ste B, Joplin, MO 64804-0394 Ph: (417) 392-0816 | David George Anthony, 1617 W 26th St Ste B, Joplin, MO 64804-0394 Ph: (417) 392-0816 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
The number of women dying due to complications during pregnancy and childbirth has decreased by 34% from an estimated 546 000 in 1990 to 358 000 in 2008, according to a new report, Trends in maternal mortality, released by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Bank.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
› Verified 6 days ago
Dr. Dana Marie Opfer, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2618 Cunningham Ave, Joplin, MO 64804 Phone: 417-623-1200 Fax: 417-623-1210 | |
Emily A Beeman, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1617 W 26th St Ste B, Joplin, MO 64804 Phone: 417-553-2003 | |
Dr. Suzanne S Long, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1920 E 32nd St, Joplin, MO 64804 Phone: 417-781-4613 Fax: 417-781-0805 | |
Mr. Hany M Mikhail, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2311 S Jackson Ave, Joplin, MO 64804 Phone: 417-781-2311 Fax: 417-781-6477 | |
Dr. Jonathan Andrew Mikhail, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2311 S Jackson Ave, Joplin, MO 64804 Phone: 417-781-2311 Fax: 417-781-6477 | |
Four States Hearing Center Llc Audiologist Medicare: Medicare Enrolled Practice Location: 1617 W 26th St Ste B, Joplin, MO 64804 Phone: 417-553-2003 |